XML 87 R5.htm IDEA: XBRL DOCUMENT v2.4.0.8
Consolidated Statements of Cash Flows (USD $)
12 Months Ended
Dec. 31, 2013
Dec. 25, 2012
Dec. 27, 2011
Cash flows from operations:      
Net Income $ 196,169,000 $ 173,448,000 $ 135,952,000
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation and amortization 106,523,000 90,939,000 79,899,000
Stock-based compensation expense 10,703,000 9,094,000 9,861,000
Tax benefit from exercise of stock options (8,100,000) (8,587,000) (4,994,000)
Increase (Decrease) in Deferred Income Taxes 10,356,000 20,334,000 1,351,000
Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal 5,764,000 3,995,000 1,789,000
Other 589,000 475,000 634,000
Changes in operating assets and liabilities, excluding the effect of acquisitions:      
Trade and other accounts receivable, net 3,021,000 (31,414,000) (16,369,000)
Inventories (2,186,000) (2,440,000) (2,183,000)
Prepaid expenses (841,000) (10,995,000) (7,323,000)
Deposits and other 1,449,000 161,000 117,000
Accounts payable 8,162,000 (6,513,000) 8,538,000
Accrued expenses 13,372,000 49,246,000 19,630,000
Deferred rent 5,868,000 5,718,000 6,081,000
Other long-term liabilities (2,432,000) (4,005,000) 3,906,000
Net cash provided by operating activities 348,417,000 289,456,000 236,889,000
Cash flows from investing activities:      
Additions to property and equipment (192,010,000) (152,328,000) (107,932,000)
Acquisitions, net of cash acquired (2,446,000) (47,951,000) (44,377,000)
Purchase of investments (97,919,000) 0 0
Proceeds from sale of investments 97,936,000 0 0
Proceeds from sale of property and equipment 0 0 115,000
Proceeds from sale-leaseback transactions 6,132,000 4,538,000 0
Net cash used in investing activities (188,307,000) (195,741,000) (152,194,000)
Cash flows from financing activities:      
Repurchase of common stock (339,409,000) (31,566,000) (96,605,000)
Exercise of employee stock options 573,000 4,455,000 3,193,000
Tax benefit from exercise of stock options 8,100,000 8,587,000 4,994,000
Proceeds from issuance of common stock under employee benefit plans 2,842,000 2,462,000 2,040,000
Debt Issuance Cost 0 (1,097,000) 0
Payment of Deferred Acquisition Holdback (4,112,000) (2,055,000) (4,976,000)
Net cash (used in) provided by financing activities (332,006,000) (19,214,000) (91,354,000)
Net (decrease) increase in cash and cash equivalents (171,896,000) 74,501,000 (6,659,000)
Cash and Cash Equivalents, at Carrying Value 297,141,000 222,640,000  
Cash and Cash Equivalents, at Carrying Value $ 125,245,000 $ 297,141,000 $ 222,640,000